共 50 条
Prediction of sudden cardiac death using artificial intelligence: Current status and future directions
被引:3
|作者:
Kolk, Maarten Z. H.
[1
,2
]
Ruiperez-Campillo, Samuel
[3
]
Wilde, Arthur A. M.
[1
,2
]
Knops, Reinoud E.
[1
,2
]
Narayan, Sanjiv M.
[4
,5
]
Tjong, Fleur V. Y.
[1
,2
]
机构:
[1] Univ Amsterdam, Heart Ctr, Dept Clin & Expt Cardiol, Amsterdam UMC Locat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Amsterdam UMC, Locat AMC, Amsterdam Cardiovasc Sci, Heart Failure & Arrhythmias, Amsterdam, Netherlands
[3] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland
[4] Stanford Univ, Dept Med, Stanford, CA USA
[5] Stanford Univ, Cardiovasc Inst, Stanford, CA USA
基金:
荷兰研究理事会;
关键词:
Artificial intelligence;
Deep learning;
Implantable cardioverter-defibrillator;
Machine learning;
Sudden cardiac death;
Ventricular arrhythmia;
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;
VENTRICULAR-ARRHYTHMIAS;
RISK STRATIFICATION;
HEART-FAILURE;
ARREST;
SURVEILLANCE;
POPULATION;
VALIDATION;
PREVENTION;
BENEFIT;
D O I:
10.1016/j.hrthm.2024.09.003
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Sudden cardiac death (SCD) remains a pressing health issue, affecting hundreds of thousands each year globally. The heterogeneity among people who suffera SCD, ranging from individuals with severe heart failure to seemingly healthy individuals, poses a significant challenge for effective risk assessment. Conventional risk stratification, which primarily relies on left ventricular ejection fraction, has resulted in only modest efficacy of implantable cardioverter-defibrillators for SCD prevention. In response, artificial intelligence (AI) holds promise for personalized SCD risk prediction and tailoring preventive strategies to the unique profiles of individual patients. Machine and deep learning algorithms have the capability to learn intricate nonlinear patterns between complex data and defined end points, and leverage these to identify subtle indicators and predictors of SCD that may not be apparent through traditional statistical analysis. However, despite the potential of AI to improve SCD risk stratification, there are important limitations that need to be addressed. We aim to provide an overview of the current state-of-the-art of AI prediction models for SCD, highlight the opportunities for these models in clinical practice, and identify the key challenges hindering widespread adoption.
引用
收藏
页码:756 / 766
页数:11
相关论文